Actual Medicinal Product (AMP) -
Risperdal Consta 37.5mg powder and solvent for prolonged-release suspension for injection vials (Originalis B.V.)
Name Details
|
Current Name
Risperdal Consta 37.5mg powder and solvent for prolonged-release suspension for injection vials
|
Start Date
01-12-2024
|
End Date
|
|
Previous Name
Risperdal Consta 37.5mg powder and solvent for suspension for injection vials
|
Start Date
15-03-2019
|
End Date
30-11-2024
|
|
|
Abbreviated Name
Risperdal Consta 37.5mg inj vials
|
Start Date
15-03-2019
|
|
Summary
- Licensed Route
- Intramuscular
- Availability Restrictions
- Not available
- Licensing Authority
- Medicines - MHRA/EMA
- Parallel Import
- Parallel Import Product
Codes
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 36873711000001102 |
15-03-2019 |
|
Actual Medicinal Product Pack (AMPP) Information